Results 71 to 80 of about 87,328 (317)
Journal of Psychoactive Drugs, 2020 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) is a potent, fast-acting psychedelic. Anecdotal reports from 5-MeO-DMT users suggest that they employ a variety of benefit enhancement (BE) strategies aimed to increase positive effects and decrease any ...
R. Lancelotta, Alan K. Davis
semanticscholar +1 more source
A Coded Bit-Loading Linear Precoded Discrete Multitone Solution for Power Line Communication [PDF]
, 2008 Linear precoded discrete multitone modulation (LP-DMT) system has been already proved advantageous with adaptive resource allocation algorithm in a power line communication (PLC) context.
Baudais, Jean-Yves +3 more
core +5 more sources
Shared Genetic Effects and Antagonistic Pleiotropy Between Multiple Sclerosis and Common Cancers
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Epidemiologic studies have reported inconsistent altered cancer risk in individuals with multiple sclerosis (MS). Factors such as immune dysregulation, comorbidities, and disease‐modifying therapies may contribute to this variability.
Asli Buyukkurt +5 more
wiley +1 more source
Frontiers in Neuroscience, 2018 N,N-dimethyltryptamine (DMT) is a powerful serotonergic psychedelic whose exogenous administration elicits striking psychedelic effects in humans. Studies have identified DMT and analogous compounds (e.g., 5-hydroxy-DMT, 5-methoxy-DMT) alongside of an ...
Jon G. Dean
doaj +1 more source
Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use
ACS Omega, 2020 To support clinical use, a multigram-scale process has been developed to provide 5-MeO-DMT, a psychedelic natural product found in the parotid gland secretions of the toad, Incilius alvarius.
A. Sherwood +4 more
semanticscholar +1 more source
Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley +1 more source
Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples
Molecules, 2020 Ayahuasca tea is a hallucinogenic beverage used for religious purposes in Brazil and many other countries that has therapeutic potential in the treatment of some mental health disorders. In the context of psychedelic research, quantification of the tea’s
Gabriela de Oliveira Silveira +5 more
semanticscholar +1 more source
On the Diversity-Multiplexing Tradeoff of Unconstrained Multiple-Access Channels [PDF]
, 2015 In this work the optimal diversity-multiplexing tradeoff (DMT) is investigated for the multiple-input multiple-output fading multiple-access channels with no power constraints (infinite constellations).
Feder, Meir, Yona, Yair
core
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen +7 more
wiley +1 more source
Neural and subjective effects of inhaled DMT in natural settings
bioRxiv, 2020 Background N,N-Dimethyltryptamine (DMT) is a short acting psychedelic tryptamine found naturally in many plants and animals. Few studies to date addressed the neural and psychological effects of DMT alone, either administered intravenously or inhaled in ...
C. Pallavicini +9 more
semanticscholar +1 more source